Expressions of vascular endothelial cadherin and soluble Fas ligand in patients with viral myocarditis and their correlations

1 Zhang ZY, Mao ZJ, Ruan YP, Zhang X. Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis. Math Biosci Eng. 2022;19(6):5772-92. DOI: 10.3934/mbe.2022270 Search in Google Scholar

2 Zaoui N, Bachir N, Terki A, Boukabous A. Myocardite à COVID-19 : « à propos d’une série monocentrique de 33 cas » [COVID-19 myocarditis : “About a monocentric series of 33 cases”]. Ann Cardiol Angeiol. 2022;71(4):219-22. DOI: 10.1016/j. ancard.2022.08.004 Search in Google Scholar

3 Zhou W, Liu K, Zeng L, He J, Gao X, Gu X, et al. Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension. Circulation. 2022;146(24):1855-81. DOI: 10.1161/CIRCULATIONAHA.122.061900 Search in Google Scholar

4 Wen XH, Wen JX, Mu L, Cao XS, Yan L, Huang JH, et al. Pleural fluid soluble Fas ligand and tuberculous pleural effusion: a prospective diagnostic test accuracy study. J Thorac Dis. 2023;15(12):6493-501. DOI: 10.21037/jtd-23-1076 Search in Google Scholar

5 Liu YX, Song YJ, Liu XH, Xu SC, Kong C, Chen LF, et al. PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy. Cytokine. 2022;157:155932. DOI: 10.1016/j. cyto.2022.155932 Search in Google Scholar

6 Zhu X, Wang X, Ying T, Li X, Tang Y, Wang Y, et al. Kaempferol alleviates the inflammatory response and stabilizes the pulmonary vascular endothelial barrier in LPS-induced sepsis through regulating the SphK1/S1P signaling pathway. Chem Biol Interact. 2022;368:110221. DOI: 10.1016/j.cbi.2022.110221 Search in Google Scholar

7 Müller M, Cooper LT, Heidecker B. Diagnosis, risk stratification and management of myocarditis. Heart. 2022;108(18):1486-97. DOI: 10.1136/heartjnl-2021-319027 Search in Google Scholar

8 Sozzi FB, Gherbesi E, Faggiano A, Gnan E, Maruccio A, Schiavone M, et al. Viral myocarditis: classification, diagnosis, and clinical implications. Front Cardiovasc Med. 2022;9:908663. DOI: 10.3389/fcvm.2022.908663 Search in Google Scholar

9 Peischard S, Möller M, Disse P, Ho HT, Verkerk AO, Strutz-Seebohm N, et al. Virus-induced inhibition of cardiac pacemaker channel HCN4 triggers bradycardia in human-induced stem cell system. Cell Mol Life Sci. 2022;79(8):440. DOI: 10.1007/s00018-022-04435-7 Search in Google Scholar

10 Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360(15):1526-38. DOI: 10.1056/NEJMra0800028 Search in Google Scholar

11 Peretto G, Sala S, Rizzo S, De Luca G, Campochiaro C, Sartorelli S, et al. Arrhythmias in myocarditis: State of the art. Heart Rhythm. 2019;16(5):793-801. DOI: 10.1016/j.hrthm.2018.11.024 Search in Google Scholar

12 Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021;19(1):5-14. DOI: 10.1080/14779072.2021.1844005 Search in Google Scholar

13 Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463-71. DOI: 10.1016/j.hrthm.2020.05.001 Search in Google Scholar

14 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169-93. DOI: 10.1038/s41569-020-00435-x Search in Google Scholar

15 Dolmatova EV, Forrester SJ, Wang K, Ou Z, Williams HC, Joseph G, et al. Endothelial Poldip2 regulates sepsis-induced lung injury via Rho pathway activation. Cardiovasc Res. 2022;118(11):2506-18. DOI: 10.1093/cvr/cvab295 Search in Google Scholar

16 Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current Understanding of the Pathogenesis of Dengue Virus Infection. Curr Microbiol. 2021;78(1):17-32. DOI: 10.1007/s00284-020-02284-w Search in Google Scholar

17 Woudstra L, Juffermans LJ, van Rossum AC, Niessen HW, Krijnen PA. Infectious myocarditis: the role of the cardiac vasculature. Heart Fail Rev. 2018;23:583-95. DOI: 10.1007/s10741-018-9688-x Search in Google Scholar

18 Flemming S, Burkard N, Renschler M, Vielmuth F, Meir M, Schick MA, et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res. 2015;107(1):32-44. DOI: 10.1093/cvr/cvv144 Search in Google Scholar

19 Lin JC, Chen ZH, Chen XD, Wang SB. Circulating sFasL Levels Predict the Severity and Outcome of Burn Injury: A Prospective Observational Study. J Surg Res. 2021;265:1-10. DOI: 10.1016/j. jss.2021.01.012 Search in Google Scholar

20 Trimarchi G, Teresi L, Licordari R, Pingitore A, Pizzino F, Grimaldi P, et al. Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers. Biomedicines. 2024;12(5):1051. DOI: 10.3390/biomedicines12051051 Search in Google Scholar

21 Shi H, Yu Y, Liu X, Yu Y, Li M, Wang Y, et al. Inhibition of calpain reduces cell apoptosis by suppressing mitochondrial fission in acute viral myocarditis. Cell Biol Toxicol. 2022;38(3):487-504. DOI: 10.1007/s10565-021-09634-9 Search in Google Scholar

22 Cui J, Zhang N, Liu Y, Zhang L, Gao C, Liu S. Microarray gene expression profiling provides insights into functions of TIPE2 in HBV-related apoptosis. Mol Immunol. 2021;131:137-43. DOI: 10.1016/j.molimm.2020.12.031 Search in Google Scholar

23 Lindrova I, Kolackova M, Svadlakova T, Vankova R, Chmelarova M, Rosecka M, et al. Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjögren’s syndrome. BMC Immunol. 2023;24(1):12. DOI: 10.1186/s12865-023-00544-5 Search in Google Scholar

24 Muraki M. Soluble Fas ligand, soluble Fas receptor, and decoy receptor 3 as disease biomarkers for clinical applications: A review. AIMS Med Sci. 2022;9(2):98-267. DOI: 10.3934/medsci.2022009 Search in Google Scholar

25 Giampietro C, Taddei A, Corada M, Sarra-Ferraris GM, Alcalay M, Cavallaro U, et al. Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood. 2012;119(9):2159-70. DOI: 10.1182/blood-2011-09-381012 Search in Google Scholar